ID

18378

Description

Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site; ODM derived from: https://clinicaltrials.gov/show/NCT00193596

Lien

https://clinicaltrials.gov/show/NCT00193596

Mots-clés

Versions (1)
  1. 02/11/2016 02/11/2016 -
Téléchargé le

2 novembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Neoplasms, Unknown Primary NCT00193596

Anglais

Eligibility Neoplasms, Unknown Primary NCT00193596

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Description

Clinical Trial Eligibility Criteria Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
carcinoma of unknown primary site
Description

Carcinoma of unknown primary origin

Type de données

boolean

Alias
UMLS CUI [1]
C0220647
biopsy-proven metastatic carcinoma
Description

Metastatic Carcinoma | Biopsy

Type de données

boolean

Alias
UMLS CUI [1]
C1384494
UMLS CUI [2]
C0005558
able to perform activities of daily living with minimal assistance
Description

Performance of activities of daily living Assisted Minimal Ability

Type de données

boolean

Alias
UMLS CUI [1,1]
C1821398
UMLS CUI [1,2]
C1269765
UMLS CUI [1,3]
C0547040
UMLS CUI [1,4]
C0085732
no previous treatment with any systemic therapy
Description

systemic therapy

Type de données

boolean

Alias
UMLS CUI [1]
C1515119
measurable or evaluable disease
Description

Measurable Disease | Evaluable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
adequate bone marrow, liver and kidney function
Description

Bone Marrow function | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
understand the nature of this study and give written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Clinical Trial Eligibility Criteria Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
age < 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
uncontrolled brain metastases and meningeal involvement
Description

Metastatic malignant neoplasm to brain Uncontrolled | Meninges Involvement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0025285
UMLS CUI [2,2]
C1314939
other uncontrolled malignancies
Description

Malignant Neoplasms Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205318
women pregnant or lactating
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
recent history of significant cardiovascular disease
Description

Cardiovascular Disease Significant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0750502
severe or uncontrolled systemic disease
Description

Systemic disease Severe | Systemic disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0442893
UMLS CUI [2,2]
C0205318
other significant clinical disorder
Description

Disease Clinical Significance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2826293
clinically active interstitial lung disease
Description

Lung Diseases, Interstitial

Type de données

boolean

Alias
UMLS CUI [1]
C0206062
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Clinical Trial Eligibility Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
Retour au début de la page

Similar models

Eligibility Neoplasms, Unknown Primary NCT00193596

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Carcinoma of unknown primary origin
Item
carcinoma of unknown primary site
boolean
C0220647 (UMLS CUI [1])
Metastatic Carcinoma | Biopsy
Item
biopsy-proven metastatic carcinoma
boolean
C1384494 (UMLS CUI [1])
C0005558 (UMLS CUI [2])
Performance of activities of daily living Assisted Minimal Ability
Item
able to perform activities of daily living with minimal assistance
boolean
C1821398 (UMLS CUI [1,1])
C1269765 (UMLS CUI [1,2])
C0547040 (UMLS CUI [1,3])
C0085732 (UMLS CUI [1,4])
systemic therapy
Item
no previous treatment with any systemic therapy
boolean
C1515119 (UMLS CUI [1])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed Consent
Item
understand the nature of this study and give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
you cannot participate in this study if any of the following apply to you:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Metastatic malignant neoplasm to brain Uncontrolled | Meninges Involvement
Item
uncontrolled brain metastases and meningeal involvement
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Malignant Neoplasms Uncontrolled
Item
other uncontrolled malignancies
boolean
C0006826 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
women pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cardiovascular Disease Significant
Item
recent history of significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Systemic disease Severe | Systemic disease Uncontrolled
Item
severe or uncontrolled systemic disease
boolean
C0442893 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0442893 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Disease Clinical Significance
Item
other significant clinical disorder
boolean
C0012634 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Lung Diseases, Interstitial
Item
clinically active interstitial lung disease
boolean
C0206062 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial